Episiotomy. Disruption of perineal obstetric wound
Conditions
Interventions
Intervention 1: Intervention group: Verbascum cream (produced in Shahid Beheshti pharmacy faculty) is used as much as one finger amount (2cm) on episiotomy wounds twice per day for 10 days. Interventi
Treatment - Drugs
Placebo
Intervention group: Verbascum cream (produced in Shahid Beheshti pharmacy faculty) is used as much as one finger amount (2cm) on episiotomy wounds twice per day for 10 days.
placebo cream (produced in Shahid Beheshti pharmacy faculty) uses topically one finger amount (2cm) on episiotomy wounds twice for 10 days
Sponsors
vice chancellor for research of School of Nursing and Midwifery of Shahid Beheshti University of Med
Eligibility
Sex/Gender
Female
Age
17 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:primiparous woman; Age between 18 to 35 years; living in the city of Saveh, Iran; At least having the ability to read and write; Non-smoking and drug abuse; Body mass index ranging from 18/5-30; Gestational age between 37 to 42 weeks; Single pregnancy with cephalic presentation; Newborn weight between 2500 to 4000 grams; Normal vaginal delivery without devices; Medio-lateral episiotomy with 4-3 cm length; Non infant hospitalization in the NICU; No have history of obstetric complications such as (preeclampsia and eclampsia, Gestational diabetes, Placental abruption, chorioamnionitis, premature rupture of memberanous more than 24 hours); No have severe anemia; Disorder of progression in time for the second stage of labor more than 14 hours more than 2 hours for the third stage more than half an hour; Non Diseases affecting wound healing (Chronic systemic disease, pulmonary disease, coagulation disorders, connective tissue, diabetes, anemia, immunodeficiency, hemophilia, malnutrition, mental disorders, renal failure); Consumption of drugs affecting wound healing (glucocorticoids, anti- coagulatives, anti- epileptic, immune system suppressants, antibiotics or chemotherapy agents); No have allergy to herbal drug; Lack of conflict between the family and the severe financial difficulties in recent months. Exclusion criteria: Unwillingness to continue participating in the study; Lack of care for designated days; Do not use ointments regularly and as directed; Allergy to verbascum cream; Hematoma in the episiotomy after delivery; The need for perineal reconstruction after episiotomy; Fever and postpartum infection; Severe constipation after childbirth during the study; Hemorrhoids or anal fissure after delivery; Use betadine or sitzbath during the study; Having sex in the first 10 days after episiotomy l
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound healing of episiotomy. Timepoint: Before intervention,24 hours after delivery, 3 and 10 days after delivery. Method of measurement: REEDA scale.;Pain intensity. Timepoint: Before intervention,24 hours after delivery, 3 and 10 days after delivery. Method of measurement: Numerical Analouge Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sedative tablets counting. Timepoint: 10 day after delivery. Method of measurement: questionnaire.;Common discontent after childbirth. Timepoint: 10 day after delivery. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGity Ozgoli
School of Nursing and Midwifery of Shahid Beheshti University of Medical Sciences
Outcome results
None listed